Fujifilm India Unveils AI-Powered CAD EYE Endoscopy in Jaipur

Fujifilm India has introduced its CAD EYE artificial intelligence endoscopy system at Fortis Hospital, Jaipur, marking a breakthrough moment for Rajasthan. This is the state’s first-ever AI-powered endoscopy installation, aimed at tackling the...

Bharat Biotech Launches Nucelion for Cell, Gene Therapy Market

Bharat Biotech International Ltd has broadened its biologics portfolio to include the launch of Nucelion Therapeutics Pvt Ltd, a 100% owned contract research, development, and manufacturing organization (CRDMO) that focuses on the development

Novo Nordisk Proposes Acquisition of Metsera in Strategic Move

Novo Nordisk has made public the submission of an unsolicited proposal to Metsera, Inc. acquisition. Metsera is a biotech company with a strong portfolio of both early and development-stage incretin and non-incretin

Normal Toothpaste for Your Child? Here's Why It Might Not Be Safe

You're standing in the toothpaste aisle at your local supermarket. One shelf has your regular adult toothpaste, the one with strong mint and whitening power.

Alkem Foundation, IIT Bombay to Launch Immunotherapy Centre

Alkem Foundation, the Corporate Social Responsibility (CSR) arm of Alkem Laboratories Ltd., has announced a strategic collaboration with the Indian Institute of Technology Bombay

Johnson & Johnson MedTech Unveils New VARIPULSE Data

Johnson & Johnson MedTech, a cardiac arrhythmia treatment global leader, said that new clinical and real-world results of its VARIPULSE™ Platform in pulsed field ablation (PFA) of atrial fibrillation (AF) would be revealed at the Asia Pacific...

Roche Wins CE Mark for Elecsys Dengue Ag Diagnostic Test

Roche announced that it has acquired the CE mark for Elecsys Dengue Ag, their high-throughput, fully-automated immunoassay system that helps the diagnosis of acute dengue virus infections.

Cipla Reports Rs 1,351.17 Cr PAT in Q2 FY26 Performance

Reflecting strong operational performance and consistent market momentum, Cipla Limited has reported a rise in both revenue and profitability for the quarter and half year ended September 30, 2025. The company’s results highlight continued growth in

Eli Lilly's Omvoh Boosts Control Over Ulcerative Colitis

Eli Lilly's Omvoh (mirikizumab) shows early and lasting relief in bowel urgency for patients with ulcerative colitis, reducing severity and frequency by over 50 percent in the Phase 3b LUCENT URGE study.

Helex Raises $3.5M to Advance Kidney Gene Therapies

Helex, a therapeutics startup operating across the US and India, has secured an oversubscribed $3.5 million Seed round led by pi Ventures, with participation from Bluehill Capital, SOSV, and a network of global investors. This latest investment bring

on the deck


Most Viewed

Editor's Guest


© 2025 India Pharma Outlook. All Rights Reserved.